News

Epicardio wins prestigious Global Cooperation grant award by Innovate UK, aiming to facilitate Epicardio’s entry into the North American medical education market. As part of this project we will start trials at leading medical schools in USA, Canada and Mexico.

Epicardio releases two CPD certified apps on the App Store and Google Play

“Temporary Cardiac Pacing”  and  “Atrial Fibrillation”

Epicardio participated in CANeLearn Leadership Summit 2021

as part of the Global Business Innovation Programme – Canada & USA EdTech hosted by Innovate UK

Dr Vassilios Hurmusiadis presenting Epicardio Simulation™ at Arrhythmias Update 2021 in Thessaloniki, Greece

Epicardio is participating in the ASU + GSV Summit 2021, under the Global Business Innovation #edtech programme hosted by Innovate UK Edge

Epicardio participating in the Global Business Innovation Programme – GBIP 2021, focused on Canada & USA #EdTech market

Programme funded by Innovate UK and UK Research and Innovation

Bienvenido a Epicardio Simulation™
Hemos diseñado esta herramienta inteligente para ayudarle a mejorar su comprensión y maestría del sistema circulatorio humano. Hemos preparado tutoriales interactivos que cubren los casos clínicos más comunes y también los mas difíciles, como las arrítmias, los marcapasos y EF Cardiaca.

Epicardio releases the Temporary Cardiac Pacing App – 3D TCP Training Simulator

Developed for health care professionals, medical and nursing students who are interested in a deeper understanding of temporary cardiac pacing procedures. This independently validated app employs interactive real-time 3D exploration into Temporary Cardiac Pacing to aid learning. The app is available on the App Store and on Google Play. All text is available in English and German.

Epicardio releases the “Atrial Fibrillation” app – 3D AFib training simulator.

Developed for healthcare professionals, medical and nursing students who are interested in a deeper understanding of Atrial Fibrillation. This independently validated app employs interactive real-time 3D exploration into Atrial Fibrillation to aid learning. Available on the App Store and on Google Play in English, German and Mandarin.

Epicardio Simulation™ is celebrating 8,127 accesses from 3,081 individual users worldwide this year, so far and counting.  A total of 3,881 hours were spent on the Epicardio app, with 67 minutes average daily usage.  v3.0 is now released with improved interactive tutorials, MCQ tests and quizzes, all validated by independent expert Cardiac Physiologists from Barts Heart Centre and the Royal Brompton Hospital in London, UK.